Drug Approval | August 27, 2024
Merck receives EC approval for Winrevair for treatment of PAH
Winrevair is the first activin signaling inhibitor therapy for PAH approved in Europe
Winrevair is the first activin signaling inhibitor therapy for PAH approved in Europe
PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Majority of organizations are looking to increase investments in public and hybrid cloud
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
This project is supported by the Irish Government through IDA Ireland
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Dr. Jitendra Singh’s pioneering work on “Stress Diabetes in Kashmiri Migrants” was hailed by the World Health Organization
Subscribe To Our Newsletter & Stay Updated
